tradingkey.logo
搜尋

GeneDx Holdings Corp

WGS
添加自選
39.920USD
+0.980+2.52%
交易中 美東報價延遲15分鐘
1.18B總市值
虧損本益比TTM

GeneDx Holdings Corp

39.920
+0.980+2.52%

關於 GeneDx Holdings Corp 公司

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

GeneDx Holdings Corp簡介

公司代碼WGS
公司名稱GeneDx Holdings Corp
上市日期Sep 04, 2020
CEOStueland (Katherine A)
員工數量1000
證券類型Ordinary Share
年結日Sep 04
公司地址333 Ludlow Street
城市STAMFORD
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編06902
電話18887291206
網址https://sema4.com/
公司代碼WGS
上市日期Sep 04, 2020
CEOStueland (Katherine A)

GeneDx Holdings Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
4.44M
+99.55%
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
34.94K
+0.28%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
4.44M
+99.55%
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
34.94K
+0.28%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Patients with third party insurance
345.24M
80.75%
Institutional customers
70.07M
16.39%
Other
10.87M
2.54%
Self pay patients
1.36M
0.32%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Patients with third party insurance
345.24M
80.75%
Institutional customers
70.07M
16.39%
Other
10.87M
2.54%
Self pay patients
1.36M
0.32%

股東統計

更新時間: 14 小時前
更新時間: 14 小時前
持股股東
股東類型
持股股東
持股股東
佔比
Meister (Keith A)
14.95%
Corvex Management LP
14.93%
Icahn School of Medicine at Mount Sinai
4.63%
OPKO Health Inc
4.62%
Westfield Capital Management Company, L.P.
4.61%
其他
56.27%
持股股東
持股股東
佔比
Meister (Keith A)
14.95%
Corvex Management LP
14.93%
Icahn School of Medicine at Mount Sinai
4.63%
OPKO Health Inc
4.62%
Westfield Capital Management Company, L.P.
4.61%
其他
56.27%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
35.13%
Investment Advisor
33.09%
Hedge Fund
32.91%
Corporation
10.37%
Research Firm
6.51%
Individual Investor
1.81%
Pension Fund
0.40%
Bank and Trust
0.39%
Sovereign Wealth Fund
0.23%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q4
456
30.28M
113.16%
--
2026Q1
549
32.98M
111.70%
+333.95K
2025Q4
500
30.62M
105.95%
-3.52M
2025Q3
446
32.52M
112.51%
-918.42K
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Corvex Management LP
3.06M
10.44%
--
--
Dec 31, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.69%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.68%
-800.83K
-36.88%
Nov 20, 2024
Westfield Capital Management Company, L.P.
1.02M
3.48%
+474.17K
+87.15%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
1.34M
4.58%
+25.70K
+1.95%
Dec 31, 2025
ARK Investment Management LLC
604.56K
2.06%
+157.58K
+35.25%
Dec 31, 2025
Goldman Sachs & Company, Inc.
1.02M
3.48%
+17.80K
+1.78%
Dec 31, 2025
Summit Partners Public Asset Management, LLC
920.59K
3.14%
+97.02K
+11.78%
Dec 31, 2025
Oracle Investment Management, Inc.
884.65K
3.02%
-5.30K
-0.60%
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Global X Genomics & Biotechnology ETF
3.84%
Franklin Genomic Advancements ETF
3.47%
Clough Hedged Equity ETF
2.89%
Clough Select Equity ETF
2.65%
State Street SPDR S&P Health Care Services ETF
2.27%
Harbor Health Care ETF
1.85%
Innovator IBD Breakout Opportunities ETF
1.52%
ARK Genomic Revolution ETF
1.29%
Main Thematic Innovation ETF
1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
1.18%
查看更多
Global X Genomics & Biotechnology ETF
佔比3.84%
Franklin Genomic Advancements ETF
佔比3.47%
Clough Hedged Equity ETF
佔比2.89%
Clough Select Equity ETF
佔比2.65%
State Street SPDR S&P Health Care Services ETF
佔比2.27%
Harbor Health Care ETF
佔比1.85%
Innovator IBD Breakout Opportunities ETF
佔比1.52%
ARK Genomic Revolution ETF
佔比1.29%
Main Thematic Innovation ETF
佔比1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
佔比1.18%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
公告日期
除權除息日
類型
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
KeyAI